Term
Any Asthma patient needs influenza and pneumococcal shot True/False?
Patient should be treated for rhinitis, sinusitis and GERD if present T/F? |
|
Definition
|
|
Term
NAME THREE QUICK RELIEF MEDICATIONS |
|
Definition
1. Albuterol and other short acting Beta2 Agonist.
2- Short acting Acetylcholine Agonist.
3-Systemtic Corticosteriod |
|
|
Term
Name the 6 Medications used for Long term CONTROL |
|
Definition
1. inhaled corticosteriod- cornerstone of long term asthma
2. Long acting BETA2 agonist
3. leukotriene receptor modifiers
4. theophylline
5. IgE Inhibitor
6. Mast Cell Modifier |
|
|
Term
Managing ACUTE EXCERBATION of asthma has three goals:
1- Correction of significant HYPOXEMIA
2- Rapid reversal of airflow obstruction
3- Reduce recurrence of severe obstruction
4- reduce morbidity and mortality
Explain how to assess severity of acute excerbation of asthma at home- |
|
Definition
1. Measure PEAK EXPIRATORY FLOW: if less than 80% then it suggests severe exacerbation. Note the signs and symptoms such as degree of cough, breathlessness, wheezing and cheat tightness.
Initial treatment of SABA; three treatments of 2-4 puffs by MDI at 20mins intervals or single nebulizer treatment.
|
|
|
Term
After the Intitial treatment patient usually does a PEF and finds percent of best. Explain the three possible findings and treatment (home).
>80% 50%-80% <50% |
|
Definition
1. >80% is a mild exacerbation, usually no wheezing or SOB. Responses to Beta2 agonist sustained for 4 hrs. Continue using b2 agonist every 3-4hrs for 48hrs.
-call MD for follow up
2- 50%-80% moderate exacerbation usually with persistent wheeze or SOB. Add oral corticosteroids (short burst) and continue the use of b2 agonist. Call MD for more urgent follow up.
3. <50% is severe exacerbation, marked wheezing or SOB. Add oral corticosteroid (short burst) and repeat beta agonist immediately. CALL MD AND GO TO ER. |
|
|
Term
1- what is the dose of Prednisone, Methylprednisolone and Prednisolone
2- how is corticosteroid dosed?
|
|
Definition
1- 120- 180 mg/day divided doses for 48hrs, then 60-80 mg/day until PEF reachest 70%.
2. Dosed 1mg-2mg per Kg per day.
remember this is dosages for drugs for acute asthma exacerbation in ER or hospital. |
|
|
Term
Patient: suffering form 4 night awakings a month due to shortness of breath and less than 2 days in a week of using the SABA, still runs daily, and has a FEV1 of 75%. Currently on low dose ICS, ASSESS! |
|
Definition
|
|
Term
list the symptoms, nighttime awakenings, SABA use (frequency), and Lung Function (FEV1 or PEF%) for Intermittent and MILD MODERATE AND SEVERE PERSISTENT |
|
Definition
intermittent- Symp less than 2d/week, Nightwake less than 2xmonth, SABA use Less than 2d/week, Lung function greater than 80%
Mild- symp more than 2 days a week but not daily, nightwake- 3-4x month, SABA use >2days/weeek/ not daily. greater than 80% PEF
Moderate- daily symptoms, 1x week night wake, Daily SABA use, PEF 60-80%.
Severe- sympt throughout the day, 7x week nightwake, SABA use throughout the day, PEF less than 60% |
|
|
Term
step 1
Intermitten Asthma |
|
Definition
|
|
Term
|
Definition
Preferred Low dose ICS
with SABA PRN for control of symptoms.
Alternative-
Cromolyn
Nedocromil
LTRA or Theophylline |
|
|
Term
|
Definition
Preferred Medium dose ICS
OR
Low dose ICS n LABA
with alternatives of
low dose ICS and either LTRA or Theophyline |
|
|
Term
|
Definition
Medium Dose ICS and LABA
alternative
Medium dose ICS and either LTRA or Theophylline |
|
|
Term
|
Definition
Preferred High dose ICS and LABA
and CONSIDER
Omalizumab for patients with allergies! |
|
|
Term
|
Definition
Preferred High dose ICS and LABA and ORAL corticosteroids
and Consider
omalizumab for patients with allergies! |
|
|
Term
if a patient has less than 2 days a week of symptoms and 1-3x a week nighttime awakwenings, uses the SABA about 2/d/week, No interference with Normal activites... with a PEF greater than 80%
is this patient controlled? well or not..
|
|
Definition
Well control= <2day/week symptoms, <2x/month nightwake/ <2days/weekSABA/ No interference with physical activites PEF>80%
recommended maintain current step and follow regular checkups 1-6months.
NOT WELL CONTROLLED= >2DAYS/WEEK(NOT DAILY) OF SYMPTOMS, 1-3X WEEK NIGHTWAKE, >2D/WEEK OF SABA USE
SOME LIMITATION OF ACTIVITIES, PEF60-80%, CONSIDER SHORTBURST STRERIOD {STEP UP ONE STEP AND REVALUATE}
|
|
|
Term
|
Definition
Symptoms throughout the day
nighttime awakingins- 4xweek
SABA use several times per day more than 2 days a week.
extremely limiting physical activities
less than 60% PEF
consider short burst oral corticosteroid
STEP UP 2 STEPS AND REEVALUATE IN 2-6 WEEKS. |
|
|
Term
ICE?
BEFORE CHANGING THERAPY, NEED TO ASSESS OTHER REASONS FOR POOR ASTHMA CONTROL. |
|
Definition
I-INHALED COMPLIANCE
C- COMPLIANCE
E- ENVIROMENTAL CHANGE
|
|
|
Term
B2 SELECTIVE AGONIST
SHORT ACTING!!
I WANT ROUTE, ONSET and DOA |
|
Definition
1-albuterol- PO-30mins onset, 4-8 DOA INH- 5mins onset, 3-6 DOA.
2. Bitolterol- INH less than 5min Onset and 4-8 DOA
3. Levabuterol- INH less than 5min onset with 3-6hr DOA
4. Pirbuterol INH less than 5min Onset with 4-8hr DOA
5. Terbutaline- PO<30mins Onset 4-8DOA
SC<15mins onset 2-4 DOA
INH<5mins Onset 3-6 DOA
|
|
|
Term
Long acting Beta 2 selective agonist
Route- onset- DOA and Dosage |
|
Definition
Formoterol (foradil) DPI 5min onset with 12hr DOA
Salmeterol- (Serevent) DPI <30mins onset and12hr DOA |
|
|
Term
What are some Adverse Effects of Beta agonist
|
|
Definition
increase HR
can cause tremmors, Shakiness, Can cause low potassium ( usually with PO or SUBQ)(this low K is probably due to a shift in the potassium from out to into the cell) monitor for hypokalemia. |
|
|
Term
How would one monitor for
1. Efficacy
2. Toxicity
with Beta 2 Blockers! |
|
Definition
1- Efficacy monitor Peak Flow , signs and symptoms and usage of SABA.
2. Toxicity- Heart rate, tremors, and K if its PO or SQ. |
|
|
Term
Mast Cell stabilizers!
name- indications, and AE |
|
Definition
Cromolyn (intal)- MDI, DPI, nebulized solution
Nedocromil (Tilade)- MDI
indications- long term prevention of symptoms, prevention of allergen induced bronchospasm and exercse induced asthma, response seen in 2 weeks but 4-6 for maximal benefits. disadvantage- need to be dosed 3-4times a day.
AE- 15-20% complain of unplesant taste from nedocromil, preferred over corticosteroids for anti-inflammatory action in children. |
|
|
Term
|
Definition
Used as anti-Inflammatory
Inhaled- long term prevention of symptoms
Systemic- short-course burst following an acute exacerbation or to gain quick control of poorly controlled asthma.
systemic for long term prevention (step 6) |
|
|
Term
what are the Adverse Effects of Inhaled and systemic corticosteriods |
|
Definition
inhaled- cough, dysphonia, oral thrust ( candidiasis)
Systemic- increase glucouse and appetite, some fluid retention, weight gain, mood alteration and even hypertension and peptic ulcer , with long term use.. adrenal axis suppression, growth suppression, cushin syndrome, osteoporosis and muscle weakness. |
|
|
Term
8 Corticosteriods, name them and long medium and high dose!
|
|
Definition
Beclomethasone (Qvar) HFA(40or 80mcg/puff) L-80-240mcg M-240-480mcg H- >480mcg
Budesonide (pulmocort)(DPI) 90-180-160mcg/inh L-180-600mcg M-600-1200mcg H->1200mcg
Ciclesonide (Alvesco) 80mcg, 160mcg L-80-160mcg M-160mcg-320mcg H>320mcg.
Flunisolide (Aerobid) 250mcg/puff L- 500-1000mcg M 1000mcg-2000mcg L- >2000mcg
Flunisolide HFA- 80mcg/puff L-320 mcg M 320-640mcg H- >640mcg
Fluticasone (flovent) HFA/MDI- 44, 110, L- 220mcg/puff 88-264 M
|
|
|